Use of a pharmaceutically acceptable oxalate derivative for the treatment of skin conditions
US6114389A · kind A · utility
7Cited by
3References
32Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Nov 19, 1997 |
| Grant date | Sep 5, 2000 |
| Priority date | — |
| Expiry date | Nov 19, 2017 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides a method for the treatment of a condition, disorder or a disease of the skin by administering a pharmaceutically acceptable oxalate. Preferably, the oxalate is a transition metal oxalate and the pharmaceutically acceptable carrier is an ointment.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.